About Our Approach to Clinical Trials
Clinical trials are research studies that explore new possibilities for finding, preventing, treating, and managing illness.
Community is at the heart of everything we do. We want to ensure that our patients have access to the very latest treatments as well as the doctors and nurses with experience in administering them. Many times, these treatment options involve being part of a clinical trial.
Montefiore Einstein Comprehensive Cancer Center is involved in more than 500 clinical trials. Through them we’re able to provide patients with access to treatments not yet available to the general public.
Today’s current treatments for cancer were all a part of a clinical trial at one point. Findings from clinical trials can ultimately provide new cancer treatment strategies for people in our community and beyond.

Integrating Discovery into Care
While we have a strong focus on clinical research studies for the types of cancers that most commonly affect our community—such as lung cancer, colorectal cancer, cervical cancer, and prostate cancer—we’re conducting research in many types of cancer.
Regardless of the type of cancer, our goal is to provide the highest quality of care. We collaborate with our patients to map out a personalized treatment pathway, which may include partnering with our doctors and researchers to participate in a clinical trial.
We encourage everyone to ask their care team if a clinical trial is an available option for care.
Partnerships That Expand Options
Clinical trials at Montefiore Einstein Comprehensive Cancer Center draw on the strength of the many partnerships we’ve built over time. We work with other NCI-designated cancer centers, academic medical centers, programs (including cooperative groups) through the National Cancer Institute (NCI), and biotechnology and pharmaceutical companies.
Montefiore Einstein Comprehensive Cancer Center physicians and patients have access to clinical trials and novel therapies. This also means our patients may be able to receive and experience potentially new ways to screen, diagnose and treat cancer.
In addition to research on ways to treat cancer, we’re studying ways to lessen side effects from treatments, and improve the quality of life for those who are actively receiving or have finished treatment.
What Are Clinical Trials?
Clinical trials are research studies that involve people. Through clinical trials, doctors find new ways to improve treatments and the quality of life for people with certain diseases.
Researchers design cancer clinical trials to test new ways to:
- Treat cancer
- Find and diagnose cancer
- Prevent cancer
- Manage symptoms of cancer and side effects from its treatment
Clinical trials are the final step in a long research process that begins in a laboratory. Before any new treatment is used with people in clinical trials, researchers work for many years to understand its effects on cancer cells in the laboratory. They also try to figure out the side effects it may cause.
Any time you or a loved one needs treatment for cancer, clinical trials are an option to think about. Trials are available for all stages of cancer. It is a myth that they are only for people who have advanced cancer that is not responding to treatment. Ask your doctor about clinical trials that might be an option for you. You can also look for trials yourself by visiting Find NCI-Supported Clinical Trials.
Every clinical trial has a person in charge, usually a doctor, who is called the principal investigator. The principal investigator prepares a plan for the trial, called a protocol. The protocol explains what will be done during the trial. It also contains information that helps the doctor decide if this treatment is right for you. The protocol includes information about:
- The reason for doing the trial
- Who can join the trial (called “eligibility criteria”)
- How many people are needed for the trial
- Any drugs or other treatments that will be given, how they will be given, the dose, and how often
- What medical tests will be done and how often
- What types of information will be collected about the people taking part
Why Are Clinical Trials Important?
Today, people are living longer through successful cancer treatments that are the results of past clinical trials. Through clinical trials, physicians determine whether new treatments are safe and effective and work better than current treatments. Clinical trials also help us find new ways to prevent and detect cancer. And they help us improve the quality of life for people during and after treatment. When you take part in a clinical trial, you add to our knowledge about cancer and help improve cancer care for future patients. Clinical trials are the key to making progress against cancer.

Types of Clinical Trials
There are several types of cancer clinical trials, including treatment trials, prevention trials, screening trials, supportive and palliative care trials, and natural history studies. Each type of trial is designed to answer different research questions and will help researchers learn things that will benefit people in the future.
Deciding to Partner & Participate in a Clinical Trial
Please contact us at mmc-cancerclinicaltrialsreferrals@montefiore.org for information about our currently enrolling clinical trials.
Questions to Ask Your Doctor About Treatment Clinical Trials
If you are thinking about taking part in a clinical trial, be sure to ask your doctor, “Is there a clinical trial that I can join?” If your doctor offers you a trial, here are some questions you may want to ask:

Paying for Clinical Trials
Learn about the different types of costs related to taking part in a clinical trial, and who is expected to pay for which costs.
As you think about taking part in a clinical trial, you will face the issue of how to cover the costs of care. There are two types of costs in a clinical trial: patient care costs and research costs.
Patient care costs are those costs related to treating your cancer, whether you are in a trial or receiving standard treatment. These costs are often covered by health insurance. These costs include:
- Doctor visits
- Hospital stays
- Standard cancer treatments
- Treatments to improve symptoms of cancer or side effects from treatment
- Lab tests
- X-rays and other imaging tests
Research costs are costs related to taking part in the trial. Often these costs are not covered by health insurance, but they may be covered by the trial’s sponsor. Examples of these costs include:
- The study drug
- Lab tests performed purely for research purposes
- Added x-rays and imaging tests performed solely for the trial
When taking part in a clinical trial, there may be extra doctor visits compared to standard treatment. During these visits, your doctor carefully watches for side effects and safety in the study. These extra visits can add costs for transportation, housing, food, and child care.
- Cáncer de mama
ENSAYO I-SPY: Nuevos agentes adaptativos personalizados y neoadyuvantes para tratar el cáncer de mama
-
Afecciones
Cáncer de mama
- Neoplasias hematológicas múltiples
Estudio de seguridad y eficacia que evalúa el uso de CTX131 en sujetos adultos con neoplasias hematológicas recidivantes o refractarias
-
Afecciones
Neoplasias hematológicas múltiples
- Leucemia linfocÃtica crónica
- Linfoma difuso de células B grandes
- Leucemia linfocÃtica aguda
Estudio de fase 1/2 de Rapcabtagene Autoleucel en LLC/SLL, LBDCG de tercera lÃnea, LLA R/R y LBDCG HR de primera lÃnea
-
Afecciones
Leucemia linfocÃtica crónica, linfoma difuso de células B grandes, leucemia linfocÃtica aguda
- Cáncer endometrial
Prueba de la adición del inhibidor de AKT, ipatasertib, al tratamiento con el agente hormonal acetato de megestrol para cánceres endometriales recurrentes o metastásicos
-
Afecciones
Cáncer endometrial
- Cáncer de pulmón de células pequeñas en estadio limitado
Estudio que evalúa el tarlatamab después de la quimiorradioterapia en el cáncer de pulmón de células pequeñas en estadio limitado (LS-SCLC)
-
Afecciones
Cáncer de pulmón de células pequeñas en estadio limitado
- Múltiple
Estudio para determinar la eficacia, seguridad y tolerabilidad del HT-001 tópico para el tratamiento de toxicidades cutáneas asociadas con inhibidores del receptor del factor de crecimiento epidérmico
-
Afecciones
Múltiple
- Cáncer de pulmón
Estudio para evaluar Durvalumab (D) neoadyuvante y quimioterapia basada en platino (CT), seguido de cirugÃa con Durvalumab adyuvante o quimiorradioterapia (CRT) con consolidación de D, en cáncer de pulmón de células no pequeñas (CPCNP) estadio IIB-IIIB, resecable o marginalmente resecable (MDT-BRIDGE)
-
Afecciones
Cáncer de pulmón
- Cáncer urotelial/de vejiga
Estudio de BT8009 como monoterapia o en combinación en participantes con cáncer urotelial localmente avanzado o metastásico (Duravelo-2)
-
Afecciones
Cáncer urotelial/de vejiga